Metastatic dermatosis in breast carcinoma on adjuvant trastuzumab: Is skin a sanctuary site in human epidermal growth factor receptor-2-amplified disease?

Metastatic dermatosis in breast carcinoma on adjuvant trastuzumab: Is skin a sanctuary site in human epidermal growth factor receptor-2-amplified disease?

Cutaneous metastasis (CM) from internal malignancies is commonly seen. Sometimes, skin metastases can be the first sign of advanced cancer or an indicator of cancer recurrence. Cases of breast cancer with cutaneous progression after or during trastuzumab therapy have been described in the past, freq...

Full description

Bibliographic Details
Main Authors: Amit Sehrawat, Sumedha A Kotwal, K M Parthasarathy
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:Indian Journal of Dermatology
Subjects:
Breast cancer
cutaneous metastasis
human epidermal growth factor receptor-2
trastuzumab
Online Access:http://www.e-ijd.org/article.asp?issn=0019-5154;year=2018;volume=63;issue=5;spage=424;epage=426;aulast=Sehrawat

Internet

http://www.e-ijd.org/article.asp?issn=0019-5154;year=2018;volume=63;issue=5;spage=424;epage=426;aulast=Sehrawat

Similar Items